Bull case
NOC would need investors to value it at roughly 29x earnings — about 11x more generous than today's 19x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where NOC stock could go
NOC would need investors to value it at roughly 29x earnings — about 11x more generous than today's 19x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
At 22x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
If investor confidence fades or macro conditions deteriorate, a 5x multiple contraction could push NOC down roughly 25% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Northrop Grumman is a major aerospace and defense contractor that designs, develops, and manufactures advanced military aircraft, space systems, and defense technologies. It generates revenue primarily through long-term government contracts across four segments: Aeronautics Systems (~30%), Defense Systems (~20%), Mission Systems (~25%), and Space Systems (~25%). The company's moat lies in its deep expertise in classified defense programs, complex systems integration capabilities, and entrenched relationships with the U.S. Department of Defense and intelligence agencies.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $7.11/$6.92 | +2.7% | $10.4B/$10.1B | +2.9% |
| Q4 2025 | $7.67/$6.44 | +19.1% | $10.4B/$10.7B | -2.7% |
| Q1 2026 | $7.23/$6.98 | +3.6% | $11.7B/$11.6B | +0.8% |
| Q2 2026 | $6.14/$6.06 | +1.3% | $9.9B/$9.8B | +1.3% |
NOC beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $569 — implies +9.0% from today's price.
| Metric | NOC | S&P 500 | Industrials | 5Y Avg NOC |
|---|---|---|---|---|
| Forward PE | 18.7x | 18.8x | 21.2x-12% | — |
| Trailing PE | 17.9x | 24.4x-27% | 25.6x-30% | 19.4x |
| PEG Ratio | 2.03x | 1.66x+22% | 1.65x+23% | — |
| EV/EBITDA | 15.5x | 15.2x | 13.9x+12% | 17.0x |
| Price/FCF | 22.4x | 20.7x | 20.0x+12% | 34.4x-35% |
| Price/Sales | 1.8x | 3.1x-43% | 1.6x+13% | 1.9x |
| Dividend Yield | 1.72% | 1.91% | 1.21% | 1.54% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolNOC 10.2% ROIC signals a durable competitive advantage — returns 3.9% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
~4.6 years to full repayment at current FCF run-rate
* Elevated by buyback-compressed equity — compare ROIC (10.2%) for an undistorted picture of capital efficiency.
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt). ROE marked * where buyback-compressed equity base may inflate the figure.
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 17, 2026
Northrop Grumman faces potential overruns and volatility in key programs like the B-21 Raider stealth bomber, which could impact profitability.
Shares appear overvalued at 25x P/E, with risks from contract execution and mark-to-market volatility.
The company's 10-K highlights increased focus on competitive risks, including pressure from rivals in defense and aerospace sectors.
Northrop Grumman faces exposure to geopolitical uncertainties and challenges in international business operations.
The company has recalibrated risk disclosures to reflect broader macroeconomic headwinds, including budget constraints and inflation.
While the US defense budget supports growth, shifts in funding priorities could create uncertainty for long-term programs.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 17, 2026
Northrop Grumman benefits from a wide economic moat, providing a competitive advantage in the defense sector.
The B-21 program is a key growth driver, though technical delays could pose risks.
The company is well-positioned to benefit from sustained government spending on space infrastructure.
DCF models suggest a significant margin of safety, with bull case intrinsic value up to $856.
Northrop Grumman remains a primary way to invest in essential global defense infrastructure.
Historical revenue and EPS growth support the bullish investment thesis.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
NOC NOC Northrop Grumman Corporation | $74.1B | 18.7x | +4.0% | 10.8% | Buy | +40.7% |
LMT LMT Lockheed Martin Corporation | $117.8B | 17.1x | +4.8% | 6.4% | Buy | +24.3% |
RTX RTX RTX Corporation | $249.9B | 26.7x | +6.0% | 8.0% | Buy | +20.9% |
GD GD General Dynamics Corporation | $94.7B | 21.0x | +5.4% | 8.1% | Buy | +17.5% |
BA BA The Boeing Company | $175.6B | — | +7.8% | 2.5% | Buy | +26.4% |
HII HII Huntington Ingalls Industries, Inc. | $11.2B | 16.5x | +4.4% | 4.7% | Hold | +47.1% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
NOC returns 3.9% annually — 1.72% through dividends and 2.2% through buybacks.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $4.78 | — | — | — |
| 2025 | $8.99 | +11.7% | 2.0% | 3.6% |
| 2024 | $8.05 | +9.7% | 3.6% | 5.4% |
| 2023 | $7.34 | +8.6% | 2.1% | 3.7% |
| 2022 | $6.76 | +9.7% | 1.8% | 3.0% |
Common questions answered from live analyst data and company financials.
Northrop Grumman Corporation (NOC) is rated Buy by Wall Street analysts as of 2026. Of 35 analysts covering the stock, 20 rate it Buy or Strong Buy, 14 rate it Hold, and 1 rate it Sell or Strong Sell. The consensus 12-month price target is $734, implying +40.7% from the current price of $522. The bear case scenario is $394 and the bull case is $823.
The Wall Street consensus price target for NOC is $734 based on 35 analyst estimates. The high-end target is $815 (+56.3% from today), and the low-end target is $620 (+18.9%). The base case model target is $625.
NOC trades at 18.7x times forward earnings. The stock currently trades at a discount to the broader market. Based on current multiples versus the peer group, the relative model signals slightly cheap versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for NOC in 2026 are: (1) Contract execution risks — Northrop Grumman faces potential overruns and volatility in key programs like the B-21 Raider stealth bomber, which could impact profitability. (2) Valuation concerns — Shares appear overvalued at 25x P/E, with risks from contract execution and mark-to-market volatility. (3) Competitive market dynamics — The company's 10-K highlights increased focus on competitive risks, including pressure from rivals in defense and aerospace sectors. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates NOC will report consensus revenue of $44.1B (+4.0% year-over-year) and EPS of $30.86 (-3.9% year-over-year) for the upcoming fiscal year. The following year, analysts project $46.7B in revenue.
Northrop Grumman Corporation is expected to report its next earnings on approximately 2026-07-23. Consensus expects EPS of $6.81 and revenue of $10.8B. Over recent quarters, NOC has beaten EPS estimates 92% of the time.
Northrop Grumman Corporation (NOC) generated $3.3B in free cash flow over the trailing twelve months — a free cash flow margin of 7.8%. NOC returns capital to shareholders through dividends (1.7% yield) and share repurchases ($1.6B TTM).